|
|
|||
|
||||
OverviewMajor depressive disorder (MDD) is the leading cause of disability globally in both developed and developing nations. The staggering economic costs attributable to MDD are largely a consequence of impairment in role function. Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principal determinant of health outcome. This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research and clinical purposes is provided. Multimodality treatments and prevention strategies are described. This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers and other stakeholders interested in improving health outcomes in MDD. Full Product DetailsAuthor: Roger S. McIntyre (University of Toronto) , Danielle S. Cha (University of Toronto)Publisher: Cambridge University Press Imprint: Cambridge University Press Dimensions: Width: 16.00cm , Height: 2.00cm , Length: 24.00cm Weight: 0.780kg ISBN: 9781107074583ISBN 10: 1107074584 Pages: 370 Publication Date: 17 March 2016 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In stock We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationRoger S. McIntyre is Head of the Mood Disorders Psychopharmacology Unit, University Health Network, and Professor of Psychiatry and Pharmacology, University of Toronto, ON, Canada. Danielle S. Cha is a Researcher at the Institute of Medical Science, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. Tab Content 6Author Website:Countries AvailableAll regions |